Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine preventionHo, Tony W ; Connor, Kathryn M ; Zhang, Ying ; Pearlman, Eric ; Koppenhaver, Janelle ; Fan, Xiaoyin ; Lines, Christopher ; Edvinsson, Lars ; Goadsby, Peter J ; Michelson, DavidNeurology, 2014-09, Vol.83 (11), p.958-966 [Periódico revisado por pares]United States: American Academy of NeurologyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trialHo, Tony W, Dr ; Ferrari, Michel D, Prof ; Dodick, David W, Prof ; Galet, Vince, PhD ; Kost, James, PhD ; Fan, Xiaoyin, PhD ; Leibensperger, Heather, BS ; Froman, Samar, BS ; Assaid, Christopher, PhD ; Lines, Christopher, PhD ; Koppen, Hille, MD ; Winner, Paul K, DOThe Lancet (British edition), 2008-12, Vol.372 (9656), p.2115-2123 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialMichelson, David, Dr ; Snyder, Ellen, PhD ; Paradis, Erin, BSN ; Chengan-Liu, Mary, PhD ; Snavely, Duane B, MA ; Hutzelmann, Jill, MS ; Walsh, James K, PhD ; Krystal, Andrew D, MD ; Benca, Ruth M, MD ; Cohn, Martin, MD ; Lines, Christopher, PhD ; Roth, Thomas, PhD ; Herring, W Joseph, MDLancet neurology, 2014-05, Vol.13 (5), p.461-471 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraineHewitt, David J ; Aurora, Sheena K ; Dodick, David W ; Goadsby, Peter J ; Ge, Yang (Joy) ; Bachman, Robert ; Taraborelli, Donna ; Fan, Xiaoyin ; Assaid, Christopher ; Lines, Christopher ; Ho, Tony WCephalalgia, 2011-04, Vol.31 (6), p.712-722 [Periódico revisado por pares]UK: SAGE PublicationsTexto completo disponível |
|
5 |
Material Type: Artigo
|
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy menSun, Hong ; Kennedy, William P ; Wilbraham, Darren ; Lewis, Nicole ; Calder, Nicole ; Li, Xiaodong ; Ma, Junshui ; Yee, Ka Lai ; Ermlich, Susan ; Mangin, Eric ; Lines, Christopher ; Rosen, Laura ; Chodakewitz, Jeffrey ; Murphy, Gail MSleep (New York, N.Y.), 2013-02, Vol.36 (2), p.259-267 [Periódico revisado por pares]United States: Associated Professional Sleep Societies, LLCTexto completo disponível |
|
6 |
Material Type: Artigo
|
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxisChabi, Almira ; Zhang, Ying ; Jackson, Saheeda ; Cady, Roger ; Lines, Christopher ; Herring, W Joseph ; Connor, Kathryn M ; Michelson, DavidCephalalgia, 2015-04, Vol.35 (5), p.379-388 [Periódico revisado por pares]London, England: SAGE PublicationsTexto completo disponível |
|
7 |
Material Type: Artigo
|
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive ImpairmentTHAL, Leon J ; FERRIS, Steven H ; REINES, Scott A ; KIRBY, Louis ; BLOCK, Gilbert A ; LINES, Christopher R ; YUEN, Eric ; ASSAID, Christopher ; NESSLY, Michael L ; NORMAN, Barbara A ; BARANAK, Christine CNeuropsychopharmacology (New York, N.Y.), 2005-06, Vol.30 (6), p.1204-1215 [Periódico revisado por pares]New York, NY: Nature PublishingTexto completo disponível |
|
8 |
Material Type: Artigo
|
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseEgan, Michael F ; Mukai, Yuki ; Voss, Tiffini ; Kost, James ; Stone, Julie ; Furtek, Christine ; Mahoney, Erin ; Cummings, Jeffrey L ; Tariot, Pierre N ; Aisen, Paul S ; Vellas, Bruno ; Lines, Christopher ; Michelson, DavidAlzheimer's research & therapy, 2019-08, Vol.11 (1), p.68-68, Article 68 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Lack of Efficacy of the Substance P (Neurokinin 1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive DisorderKeller, Martin ; Montgomery, Stuart ; Ball, William ; Morrison, Mary ; Snavely, Duane ; Liu, Guanghan ; Hargreaves, Richard ; Hietala, Jarmo ; Lines, Christopher ; Beebe, Katherine ; Reines, ScottBiological psychiatry (1969), 2006-02, Vol.59 (3), p.216-223 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized TrialConnor, Kathryn M. ; Aurora, Sheena K. ; Loeys, Tom ; Ashina, Messoud ; Jones, Christopher ; Giezek, Hilde ; Massaad, Rachid ; Williams-Diaz, Angela ; Lines, Christopher ; Ho, Tony W.Headache, 2011-01, Vol.51 (1), p.73-84 [Periódico revisado por pares]Malden, USA: Blackwell Publishing IncTexto completo disponível |